Knowles Corporation (KN) Q3 2024 Earnings Call Transcript Summary
Knowles Corporation (KN) Q3 2024 Earnings Call Transcript Summary
EPS for Q3 was $0.26, reflecting a 30% increase from the previous year.The following is a summary of the Knowles Corporation (KN) Q3 2024 Earnings Call Transcript:
以下是Knowles公司（KN）2024年第三季度業績會議呈文摘要：
Financial Performance:
金融業績：
Knowles Corporation reported a Q3 revenue of $143 million, driven by a 32% growth year-over-year and organic growth of 4%.
Adjusted EBITDA margins stood at 24.6%, with expectations of further margin expansion.
EPS for Q3 was $0.26, reflecting a 30% increase from the previous year.
Knowles公司報告第三季度營業收入爲$14300萬，同比增長32％，有機增長爲4％。
調整後的EBITDA利潤率爲24.6％，預期會進一步擴張利潤率。
第三季度每股收益爲$0.26，比去年同期增長30％。
Business Progress:
業務進展：
Successfully signed a definitive agreement to sell the Consumer MEMS Microphone business, aligning with strategic focus on high growth markets.
Expects robust Q4 revenue driven by new product launches in the hearing health market.
Anticipates close of the Consumer MEMS Microphone business sale by end of Q4 and hosting an Investor Forum in Q1 2025.
Achieved synergies and operational improvements from the Cornell acquisition, which significantly contributed to revenue and margin growth.
成功簽署了一項明確協議，出售消費類MEMS麥克風業務，符合戰略重點放在高增長市場上。
預計由聽力健康市場新產品推出推動的強勁第四季度營業收入。
預計在第四季度結束前完成消費類MEMS麥克風業務的出售，並在2025年第一季度舉辦投資者論壇。
通過Cornell收購實現了協同效應和運營改善，這對營業收入和利潤增長產生了重要貢獻。
Opportunities:
機會：
Positive market response and expected growth in the Medtech and Specialty Audio segment, supported by recent Apple software updates promoting over-the-counter hearing aid features.
Continued growth in defense and electrification markets, with new opportunities across multiple end markets positioning for growth as market recovers in 2025.
市場對醫療技術和特種音頻領域的積極反應以及蘋果最新軟件更新的預期增長支持，促進了推廣非處方助聽器功能。
在2025年市場復甦的背景下，軍工股和電動化市場持續增長，擁有多個終端市場的新機遇，爲增長打下了基礎。
Risks:
風險：
Inconsistent bookings and ongoing inventory challenges in the industrial markets and with distribution partners, impacting the Precision Device segment's performance.
工業市場和分銷合作伙伴持續不穩定的訂單和持續存在的庫存挑戰，影響了Precision Device業務部門的表現。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
